
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15604269
[patent_doc_number] => 10583175
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Rapid-acting insulin formulation comprising a substituted anionic compound
[patent_app_type] => utility
[patent_app_number] => 15/609670
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 31159
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609670
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609670 | Rapid-acting insulin formulation comprising a substituted anionic compound | May 30, 2017 | Issued |
Array
(
[id] => 16429443
[patent_doc_number] => 10829510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Method for preparing sucralose-6-acetate in biphasic liquid-liquid system
[patent_app_type] => utility
[patent_app_number] => 16/300426
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2843
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300426
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300426 | Method for preparing sucralose-6-acetate in biphasic liquid-liquid system | May 17, 2017 | Issued |
Array
(
[id] => 16381933
[patent_doc_number] => 10806743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-10-20
[patent_title] => Method of administering lactitol to reduce plasma concentration of lactitol
[patent_app_type] => utility
[patent_app_number] => 15/594109
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10298
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15594109
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/594109 | Method of administering lactitol to reduce plasma concentration of lactitol | May 11, 2017 | Issued |
Array
(
[id] => 18186367
[patent_doc_number] => 11576925
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments
[patent_app_type] => utility
[patent_app_number] => 16/754756
[patent_app_country] => US
[patent_app_date] => 2017-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 15
[patent_no_of_words] => 23449
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754756
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/754756 | Application of low-molecular-weight hyaluronic acid (LMW-HA) fragments | Apr 24, 2017 | Issued |
Array
(
[id] => 14406749
[patent_doc_number] => 20190169218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/092938
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092938 | AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF | Apr 13, 2017 | Abandoned |
Array
(
[id] => 14516391
[patent_doc_number] => 10335429
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Association of beta-glucans and arabinoxylans
[patent_app_type] => utility
[patent_app_number] => 15/483270
[patent_app_country] => US
[patent_app_date] => 2017-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6948
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483270
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/483270 | Association of beta-glucans and arabinoxylans | Apr 9, 2017 | Issued |
Array
(
[id] => 14212247
[patent_doc_number] => 20190118508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => Resin Composite Film Including Cellulose Microfiber Layer
[patent_app_type] => utility
[patent_app_number] => 16/089508
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16089508
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/089508 | Resin composite film including cellulose microfiber layer | Mar 28, 2017 | Issued |
Array
(
[id] => 14185381
[patent_doc_number] => 20190112395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => Method of producing hemicellulose extracts
[patent_app_type] => utility
[patent_app_number] => 16/090221
[patent_app_country] => US
[patent_app_date] => 2017-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16090221
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/090221 | Method of producing hemicellulose extracts | Mar 28, 2017 | Issued |
Array
(
[id] => 12185432
[patent_doc_number] => 20180044367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'NUCLEOSIDE PHOSPHORAMIDATES'
[patent_app_type] => utility
[patent_app_number] => 15/471128
[patent_app_country] => US
[patent_app_date] => 2017-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 33451
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15471128
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/471128 | NUCLEOSIDE PHOSPHORAMIDATES | Mar 27, 2017 | Abandoned |
Array
(
[id] => 15751135
[patent_doc_number] => 10617649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-14
[patent_title] => Preparation method of azacitidine for injection
[patent_app_type] => utility
[patent_app_number] => 16/086592
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2628
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16086592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/086592 | Preparation method of azacitidine for injection | Mar 16, 2017 | Issued |
Array
(
[id] => 16428258
[patent_doc_number] => 10828319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Chitosan hydrogels for accelerating involution and preventing infection of the mammary gland at drying-off
[patent_app_type] => utility
[patent_app_number] => 16/085691
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 11040
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085691 | Chitosan hydrogels for accelerating involution and preventing infection of the mammary gland at drying-off | Mar 15, 2017 | Issued |
Array
(
[id] => 16288837
[patent_doc_number] => 10765659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-08
[patent_title] => Potentiated tulathromycin
[patent_app_type] => utility
[patent_app_number] => 16/084804
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7256
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16084804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/084804 | Potentiated tulathromycin | Mar 13, 2017 | Issued |
Array
(
[id] => 16784973
[patent_doc_number] => 10987372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Anti-hepatoma-virus agent
[patent_app_type] => utility
[patent_app_number] => 16/083762
[patent_app_country] => US
[patent_app_date] => 2017-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5425
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16083762
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/083762 | Anti-hepatoma-virus agent | Mar 9, 2017 | Issued |
Array
(
[id] => 13870715
[patent_doc_number] => 20190031698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => SEPARATION OF OLIGOSACCHARIDES FROM FERMENTATION BROTH
[patent_app_type] => utility
[patent_app_number] => 16/082848
[patent_app_country] => US
[patent_app_date] => 2017-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082848
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082848 | Separation of oligosaccharides from fermentation broth | Mar 6, 2017 | Issued |
Array
(
[id] => 14130039
[patent_doc_number] => 20190099409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => METHODS FOR ENHANCING LIVER REGENERATION
[patent_app_type] => utility
[patent_app_number] => 16/078446
[patent_app_country] => US
[patent_app_date] => 2017-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16078446
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/078446 | Methods for enhancing liver regeneration | Feb 21, 2017 | Issued |
Array
(
[id] => 13898901
[patent_doc_number] => 20190038655
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => CHEMICALS AND METHODS TO PREVENT AND TREAT TGF-BETA MEDIATED ACTIVATION OF FIBROBLASTS TO REDUCE AND TREAT CANCER AND FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 16/074566
[patent_app_country] => US
[patent_app_date] => 2017-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074566
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074566 | Chemicals and methods to prevent and treat TGF-beta mediated activation of fibroblasts to reduce and treat cancer and fibrosis | Feb 1, 2017 | Issued |
Array
(
[id] => 11625867
[patent_doc_number] => 20170136057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION'
[patent_app_type] => utility
[patent_app_number] => 15/421513
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3797
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421513
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421513 | OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION | Jan 31, 2017 | Abandoned |
Array
(
[id] => 16304131
[patent_doc_number] => 10772902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-15
[patent_title] => Use of floridoside or isethionic acid to potentiate antimicrobial activity of antibiotics
[patent_app_type] => utility
[patent_app_number] => 16/074554
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 4590
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074554 | Use of floridoside or isethionic acid to potentiate antimicrobial activity of antibiotics | Jan 26, 2017 | Issued |
Array
(
[id] => 13926081
[patent_doc_number] => 20190046556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => Methods and Pharmaceutical Compositions for the Prophylactic Treatment of Peritoneal Carcinomatosis
[patent_app_type] => utility
[patent_app_number] => 16/074598
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6937
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074598
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074598 | Methods and Pharmaceutical Compositions for the Prophylactic Treatment of Peritoneal Carcinomatosis | Jan 26, 2017 | Abandoned |
Array
(
[id] => 16946650
[patent_doc_number] => 20210205341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN INFANTS OR YOUNG CHILDREN TO PREVENT OR TREAT A HEALTH DISORDER BY INCREASING GLP-1 SECRETION
[patent_app_type] => utility
[patent_app_number] => 16/071324
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071324
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071324 | COMPOSITIONS COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN INFANTS OR YOUNG CHILDREN TO PREVENT OR TREAT A HEALTH DISORDER BY INCREASING GLP-1 SECRETION | Jan 25, 2017 | Abandoned |